396 related articles for article (PubMed ID: 12657672)
1. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.
Nguyen MD; Boudreau M; Kriz J; Couillard-Després S; Kaplan DR; Julien JP
J Neurosci; 2003 Mar; 23(6):2131-40. PubMed ID: 12657672
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
Nguyen MD; Larivière RC; Julien JP
Neuron; 2001 Apr; 30(1):135-47. PubMed ID: 11343650
[TBL] [Abstract][Full Text] [Related]
3. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25.
Takahashi S; Kulkarni AB
J Neurochem; 2004 Mar; 88(5):1295-304. PubMed ID: 15009685
[TBL] [Abstract][Full Text] [Related]
4. Cdk5 sinks into ALS.
Patzke H; Tsai LH
Trends Neurosci; 2002 Jan; 25(1):8-10. PubMed ID: 11801324
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase.
Couillard-Després S; Zhu Q; Wong PC; Price DL; Cleveland DW; Julien JP
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9626-30. PubMed ID: 9689131
[TBL] [Abstract][Full Text] [Related]
6. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
7. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.
Hamdane M; Bretteville A; Sambo AV; Schindowski K; Bégard S; Delacourte A; Bertrand P; Buée L
J Cell Sci; 2005 Mar; 118(Pt 6):1291-8. PubMed ID: 15741232
[TBL] [Abstract][Full Text] [Related]
8. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis.
Menzies FM; Grierson AJ; Cookson MR; Heath PR; Tomkins J; Figlewicz DA; Ince PG; Shaw PJ
J Neurochem; 2002 Sep; 82(5):1118-28. PubMed ID: 12358759
[TBL] [Abstract][Full Text] [Related]
9. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.
Féliers D; Frank MA; Riley DJ
Diabetes; 2002 Nov; 51(11):3290-9. PubMed ID: 12401721
[TBL] [Abstract][Full Text] [Related]
10. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase.
Kriz J; Gowing G; Julien JP
Ann Neurol; 2003 Apr; 53(4):429-36. PubMed ID: 12666110
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
12. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
13. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
14. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
Larivière RC; Beaulieu JM; Nguyen MD; Julien JP
Neurobiol Dis; 2003 Jul; 13(2):158-66. PubMed ID: 12828939
[TBL] [Abstract][Full Text] [Related]
15. Potassium-induced apoptosis in rat cerebellar granule cells involves cell-cycle blockade at the G1/S transition.
Martín-Romero FJ; Santiago-Josefat B; Correa-Bordes J; Gutierrez-Merino C; Fernandez-Salguero P
J Mol Neurosci; 2000 Dec; 15(3):155-65. PubMed ID: 11303780
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.
Pramatarova A; Laganière J; Roussel J; Brisebois K; Rouleau GA
J Neurosci; 2001 May; 21(10):3369-74. PubMed ID: 11331366
[TBL] [Abstract][Full Text] [Related]
17. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS.
Lobsiger CS; Garcia ML; Ward CM; Cleveland DW
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10351-6. PubMed ID: 16002469
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
19. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.
Kriz J; Nguyen MD; Julien JP
Neurobiol Dis; 2002 Aug; 10(3):268-78. PubMed ID: 12270689
[TBL] [Abstract][Full Text] [Related]
20. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
